학술논문
Erratum: Effects of the sodium-glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b-4 chronic kidney disease (Nephrology Dialysis Transplantation (gfx350) DOI: 10.1093/NDT/gfx350)
Document Type
Erratum
Author
Source
In: Nephrology Dialysis Transplantation . (Nephrology Dialysis Transplantation, 1 July 2018, 33(7):1280)
Subject
Language
English
ISSN
14602385
09310509
09310509